Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Biotechnology-Based Chemical Market by END USERS (Bio-pharma, Agri-biotech, Bio-informatics, Bio-services, Others) and by APPLICATIONS (Food and beverages, Agriculture, Fuel, Energy, Animal feed, Pharmaceuticals and nutrition, Paper and pulp, Cosmetics and toiletries, Plastics and fibres, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

A00589

Pages: NA

Charts: NA

Tables: NA

In Biotechnology, living systems and organisms are used to develop or modified specific product or processes. The major types of biotechnology are red, green, white, and blue biotechnology. Red biotechnology involves medical processes, white biotechnology which is also known as grey biotechnology is mainly used in industrial processes, green biotechnology involves agricultural biotech processes and blue biotechnology comprises of marine and aquatic processes. Few of the biotechnology-based chemicals available in the market are polylactic acid, polyhydroxyalkanoates, and lactic acid. Biotechnology-based chemicals has wide applications across industrial areas such as agriculture, medicine, food production, healthcare, and crop production. It is also used in other sectors such as chemicals, food and feed, paper and pulp, and detergents and bioenergy. Today, more than 13.3 million farmers are using biotechnology-based chemicals to increase the crops yield, to protect crops from insects, and to reduce the harmful impact on environment. Pharmaceutical industry is the largest consumer of biotechnology-based chemicals and thus boosts the global biotechnology-based chemical market. 

The global biotechnology-based chemical market is segmented on the basis of end users, applications, and geography. End users for biotechnology-based chemical market consist of bio-pharma, agri-biotech, bio-informatics, bio-services. Further, application market comprises of food and beverages, agriculture, fuel, energy, animal feed, pharmaceuticals and nutrition, paper and pulp, cosmetics and toiletries, and plastics and fibres. Geographically, the market is segmented as North America, Asia-Pacific, Europe, and LAMEA. 

Biotechnology-based chemical market is fragmented and few of the key players include Queensland’s world-class agriculture industry, Sarnia-Lambton Research, UK and Norway business funding agencies, the Technology Strategy Board (TSB) and Innovation Norway.

KEY BENEFITS:

  • This study provides an in-depth analysis of the biotechnology-based chemical market with current and future trends to elucidate the imminent investment pockets in the market.
  • This report also provides information regarding key drivers, restraints, and opportunities with impact analysis.
  • Quantitative analysis of the current market and estimations are provided in this report to showcase the financial caliber of the market.
  • Porter’s Five Forces model of the industry illustrates the potency of the buyers and suppliers participating in the market.
  • SWOT analysis highlights the internal environment of leading companies for effective strategy formulation.
  • Value chain analysis in the report provides a clear understanding of the roles of stakeholders involved in the value chain

 Key Market Segments

  • By END USERS
    • Bio-pharma
    • Agri-biotech
    • Bio-informatics
    • Bio-services
    • Others
  • By APPLICATIONS
    • Food and beverages
    • Agriculture
    • Fuel
    • Energy
    • Animal feed
    • Pharmaceuticals and nutrition
    • Paper and pulp
    • Cosmetics and toiletries
    • Plastics and fibres
    • Others
  • By GEOGRAPHY
    • North America
    • Asia-Pacific
    • Europe
    • LAMEA

 
Key Market Players

  • Johnson & Johnson
  • Gilead Sciences
  • Merck
  • Sanofi
  • Novozymes
  • Celgene Corporation
  • Roche
  • Pfizer
  • Amgen
  • AstraZeneca

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: BIOTECHNOLOGY-BASED CHEMICAL MARKET, BY END USERS

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By End Users

    • 4.2. Bio-pharma

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Agri-biotech

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Bio-informatics

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Bio-services

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Others

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

  • CHAPTER 5: BIOTECHNOLOGY-BASED CHEMICAL MARKET, BY APPLICATIONS

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Applications

    • 5.2. Food And Beverages

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Agriculture

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Fuel

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Energy

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Animal Feed

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

    • 5.7. Pharmaceuticals And Nutrition

      • 5.7.1. Key Market Trends, Growth Factors and Opportunities

      • 5.7.2. Market Size and Forecast, By Region

      • 5.7.3. Market Share Analysis, By Country

    • 5.8. Paper And Pulp

      • 5.8.1. Key Market Trends, Growth Factors and Opportunities

      • 5.8.2. Market Size and Forecast, By Region

      • 5.8.3. Market Share Analysis, By Country

    • 5.9. Cosmetics And Toiletries

      • 5.9.1. Key Market Trends, Growth Factors and Opportunities

      • 5.9.2. Market Size and Forecast, By Region

      • 5.9.3. Market Share Analysis, By Country

    • 5.10. Plastics And Fibres

      • 5.10.1. Key Market Trends, Growth Factors and Opportunities

      • 5.10.2. Market Size and Forecast, By Region

      • 5.10.3. Market Share Analysis, By Country

    • 5.11. Others

      • 5.11.1. Key Market Trends, Growth Factors and Opportunities

      • 5.11.2. Market Size and Forecast, By Region

      • 5.11.3. Market Share Analysis, By Country

  • CHAPTER 6: BIOTECHNOLOGY-BASED CHEMICAL MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By End Users

      • 6.2.3. Market Size and Forecast, By Applications

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Biotechnology-based Chemical Market

        • 6.2.5.1. Market Size and Forecast, By End Users
        • 6.2.5.2. Market Size and Forecast, By Applications

      • 6.2.6. Canada Biotechnology-based Chemical Market

        • 6.2.6.1. Market Size and Forecast, By End Users
        • 6.2.6.2. Market Size and Forecast, By Applications

      • 6.2.7. Mexico Biotechnology-based Chemical Market

        • 6.2.7.1. Market Size and Forecast, By End Users
        • 6.2.7.2. Market Size and Forecast, By Applications

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By End Users

      • 6.3.3. Market Size and Forecast, By Applications

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Biotechnology-based Chemical Market

        • 6.3.5.1. Market Size and Forecast, By End Users
        • 6.3.5.2. Market Size and Forecast, By Applications

      • 6.3.6. Germany Biotechnology-based Chemical Market

        • 6.3.6.1. Market Size and Forecast, By End Users
        • 6.3.6.2. Market Size and Forecast, By Applications

      • 6.3.7. Italy Biotechnology-based Chemical Market

        • 6.3.7.1. Market Size and Forecast, By End Users
        • 6.3.7.2. Market Size and Forecast, By Applications

      • 6.3.8. Spain Biotechnology-based Chemical Market

        • 6.3.8.1. Market Size and Forecast, By End Users
        • 6.3.8.2. Market Size and Forecast, By Applications

      • 6.3.9. UK Biotechnology-based Chemical Market

        • 6.3.9.1. Market Size and Forecast, By End Users
        • 6.3.9.2. Market Size and Forecast, By Applications

      • 6.3.10. Russia Biotechnology-based Chemical Market

        • 6.3.10.1. Market Size and Forecast, By End Users
        • 6.3.10.2. Market Size and Forecast, By Applications

      • 6.3.11. Rest Of Europe Biotechnology-based Chemical Market

        • 6.3.11.1. Market Size and Forecast, By End Users
        • 6.3.11.2. Market Size and Forecast, By Applications

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By End Users

      • 6.4.3. Market Size and Forecast, By Applications

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Biotechnology-based Chemical Market

        • 6.4.5.1. Market Size and Forecast, By End Users
        • 6.4.5.2. Market Size and Forecast, By Applications

      • 6.4.6. Japan Biotechnology-based Chemical Market

        • 6.4.6.1. Market Size and Forecast, By End Users
        • 6.4.6.2. Market Size and Forecast, By Applications

      • 6.4.7. India Biotechnology-based Chemical Market

        • 6.4.7.1. Market Size and Forecast, By End Users
        • 6.4.7.2. Market Size and Forecast, By Applications

      • 6.4.8. South Korea Biotechnology-based Chemical Market

        • 6.4.8.1. Market Size and Forecast, By End Users
        • 6.4.8.2. Market Size and Forecast, By Applications

      • 6.4.9. Australia Biotechnology-based Chemical Market

        • 6.4.9.1. Market Size and Forecast, By End Users
        • 6.4.9.2. Market Size and Forecast, By Applications

      • 6.4.10. Thailand Biotechnology-based Chemical Market

        • 6.4.10.1. Market Size and Forecast, By End Users
        • 6.4.10.2. Market Size and Forecast, By Applications

      • 6.4.11. Malaysia Biotechnology-based Chemical Market

        • 6.4.11.1. Market Size and Forecast, By End Users
        • 6.4.11.2. Market Size and Forecast, By Applications

      • 6.4.12. Indonesia Biotechnology-based Chemical Market

        • 6.4.12.1. Market Size and Forecast, By End Users
        • 6.4.12.2. Market Size and Forecast, By Applications

      • 6.4.13. Rest of Asia Pacific Biotechnology-based Chemical Market

        • 6.4.13.1. Market Size and Forecast, By End Users
        • 6.4.13.2. Market Size and Forecast, By Applications

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By End Users

      • 6.5.3. Market Size and Forecast, By Applications

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Biotechnology-based Chemical Market

        • 6.5.5.1. Market Size and Forecast, By End Users
        • 6.5.5.2. Market Size and Forecast, By Applications

      • 6.5.6. South Africa Biotechnology-based Chemical Market

        • 6.5.6.1. Market Size and Forecast, By End Users
        • 6.5.6.2. Market Size and Forecast, By Applications

      • 6.5.7. Saudi Arabia Biotechnology-based Chemical Market

        • 6.5.7.1. Market Size and Forecast, By End Users
        • 6.5.7.2. Market Size and Forecast, By Applications

      • 6.5.8. UAE Biotechnology-based Chemical Market

        • 6.5.8.1. Market Size and Forecast, By End Users
        • 6.5.8.2. Market Size and Forecast, By Applications

      • 6.5.9. Argentina Biotechnology-based Chemical Market

        • 6.5.9.1. Market Size and Forecast, By End Users
        • 6.5.9.2. Market Size and Forecast, By Applications

      • 6.5.10. Rest of LAMEA Biotechnology-based Chemical Market

        • 6.5.10.1. Market Size and Forecast, By End Users
        • 6.5.10.2. Market Size and Forecast, By Applications

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Novozymes

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Johnson And Johnson

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Amgen

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Merck

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Sanofi

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. AstraZeneca

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Pfizer

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Roche

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Gilead Sciences

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Celgene Corporation

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL BIOTECHNOLOGY-BASED CHEMICAL MARKET, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR BIO-PHARMA, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR AGRI-BIOTECH, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR BIO-INFORMATICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR BIO-SERVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL BIOTECHNOLOGY-BASED CHEMICAL MARKET, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR FOOD AND BEVERAGES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR AGRICULTURE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR FUEL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR ENERGY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR ANIMAL FEED, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR PHARMACEUTICALS AND NUTRITION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR PAPER AND PULP, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR COSMETICS AND TOILETRIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. GLOBAL BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR PLASTICS AND FIBRES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. GLOBAL BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 18. GLOBAL BIOTECHNOLOGY-BASED CHEMICAL MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 19. NORTH AMERICA BIOTECHNOLOGY-BASED CHEMICAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 20. NORTH AMERICA BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 21. NORTH AMERICA BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 22. U.S. BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 23. U.S. BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 24. CANADA BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 25. CANADA BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 26. MEXICO BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 27. MEXICO BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 28. EUROPE BIOTECHNOLOGY-BASED CHEMICAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 29. EUROPE BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 30. EUROPE BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 31. FRANCE BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 32. FRANCE BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 33. GERMANY BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 34. GERMANY BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 35. ITALY BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 36. ITALY BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 37. SPAIN BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 38. SPAIN BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 39. UK BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 40. UK BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 41. RUSSIA BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 42. RUSSIA BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 43. REST OF EUROPE BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 44. REST OF EUROPE BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 45. ASIA-PACIFIC BIOTECHNOLOGY-BASED CHEMICAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 46. ASIA-PACIFIC BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 47. ASIA-PACIFIC BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 48. CHINA BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 49. CHINA BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 50. JAPAN BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 51. JAPAN BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 52. INDIA BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 53. INDIA BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 54. SOUTH KOREA BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 55. SOUTH KOREA BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 56. AUSTRALIA BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 57. AUSTRALIA BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 58. THAILAND BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 59. THAILAND BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 60. MALAYSIA BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 61. MALAYSIA BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 62. INDONESIA BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 63. INDONESIA BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 64. REST OF ASIA PACIFIC BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 65. REST OF ASIA PACIFIC BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 66. LAMEA BIOTECHNOLOGY-BASED CHEMICAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 67. LAMEA BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 68. LAMEA BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 69. BRAZIL BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 70. BRAZIL BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 71. SOUTH AFRICA BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 72. SOUTH AFRICA BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 73. SAUDI ARABIA BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 74. SAUDI ARABIA BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 75. UAE BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 76. UAE BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 77. ARGENTINA BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 78. ARGENTINA BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 79. REST OF LAMEA BIOTECHNOLOGY-BASED CHEMICAL, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 80. REST OF LAMEA BIOTECHNOLOGY-BASED CHEMICAL, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 81. NOVOZYMES: KEY EXECUTIVES
  • TABLE 82. NOVOZYMES: COMPANY SNAPSHOT
  • TABLE 83. NOVOZYMES: OPERATING SEGMENTS
  • TABLE 84. NOVOZYMES: PRODUCT PORTFOLIO
  • TABLE 85. NOVOZYMES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 86. JOHNSON AND JOHNSON: KEY EXECUTIVES
  • TABLE 87. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
  • TABLE 88. JOHNSON AND JOHNSON: OPERATING SEGMENTS
  • TABLE 89. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
  • TABLE 90. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 91. AMGEN: KEY EXECUTIVES
  • TABLE 92. AMGEN: COMPANY SNAPSHOT
  • TABLE 93. AMGEN: OPERATING SEGMENTS
  • TABLE 94. AMGEN: PRODUCT PORTFOLIO
  • TABLE 95. AMGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 96. MERCK: KEY EXECUTIVES
  • TABLE 97. MERCK: COMPANY SNAPSHOT
  • TABLE 98. MERCK: OPERATING SEGMENTS
  • TABLE 99. MERCK: PRODUCT PORTFOLIO
  • TABLE 100. MERCK: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 101. SANOFI: KEY EXECUTIVES
  • TABLE 102. SANOFI: COMPANY SNAPSHOT
  • TABLE 103. SANOFI: OPERATING SEGMENTS
  • TABLE 104. SANOFI: PRODUCT PORTFOLIO
  • TABLE 105. SANOFI: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 106. ASTRAZENECA: KEY EXECUTIVES
  • TABLE 107. ASTRAZENECA: COMPANY SNAPSHOT
  • TABLE 108. ASTRAZENECA: OPERATING SEGMENTS
  • TABLE 109. ASTRAZENECA: PRODUCT PORTFOLIO
  • TABLE 110. ASTRAZENECA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 111. PFIZER: KEY EXECUTIVES
  • TABLE 112. PFIZER: COMPANY SNAPSHOT
  • TABLE 113. PFIZER: OPERATING SEGMENTS
  • TABLE 114. PFIZER: PRODUCT PORTFOLIO
  • TABLE 115. PFIZER: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 116. ROCHE: KEY EXECUTIVES
  • TABLE 117. ROCHE: COMPANY SNAPSHOT
  • TABLE 118. ROCHE: OPERATING SEGMENTS
  • TABLE 119. ROCHE: PRODUCT PORTFOLIO
  • TABLE 120. ROCHE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 121. GILEAD SCIENCES: KEY EXECUTIVES
  • TABLE 122. GILEAD SCIENCES: COMPANY SNAPSHOT
  • TABLE 123. GILEAD SCIENCES: OPERATING SEGMENTS
  • TABLE 124. GILEAD SCIENCES: PRODUCT PORTFOLIO
  • TABLE 125. GILEAD SCIENCES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 126. CELGENE CORPORATION: KEY EXECUTIVES
  • TABLE 127. CELGENE CORPORATION: COMPANY SNAPSHOT
  • TABLE 128. CELGENE CORPORATION: OPERATING SEGMENTS
  • TABLE 129. CELGENE CORPORATION: PRODUCT PORTFOLIO
  • TABLE 130. CELGENE CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOTECHNOLOGY-BASED CHEMICAL MARKET SEGMENTATION
  • FIGURE 2. GLOBAL BIOTECHNOLOGY-BASED CHEMICAL MARKET
  • FIGURE 3. SEGMENTATION BIOTECHNOLOGY-BASED CHEMICAL MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN BIOTECHNOLOGY-BASED CHEMICAL MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALBIOTECHNOLOGY-BASED CHEMICAL MARKET
  • FIGURE 11. BIOTECHNOLOGY-BASED CHEMICAL MARKET SEGMENTATION, BY BY END USERS
  • FIGURE 12. BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR BIO-PHARMA, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR AGRI-BIOTECH, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR BIO-INFORMATICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR BIO-SERVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. BIOTECHNOLOGY-BASED CHEMICAL MARKET SEGMENTATION, BY BY APPLICATIONS
  • FIGURE 18. BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR FOOD AND BEVERAGES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR AGRICULTURE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR FUEL, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR ENERGY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR ANIMAL FEED, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR PHARMACEUTICALS AND NUTRITION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR PAPER AND PULP, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR COSMETICS AND TOILETRIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 26. BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR PLASTICS AND FIBRES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 27. BIOTECHNOLOGY-BASED CHEMICAL MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 28. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 29. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 30. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 31. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 32. COMPETITIVE DASHBOARD
  • FIGURE 33. COMPETITIVE HEATMAP: BIOTECHNOLOGY-BASED CHEMICAL MARKET
  • FIGURE 34. TOP PLAYER POSITIONING, 2024
  • FIGURE 35. NOVOZYMES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. NOVOZYMES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. NOVOZYMES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. JOHNSON AND JOHNSON: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. AMGEN: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. AMGEN: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. AMGEN: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. MERCK: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. MERCK: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. MERCK: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. SANOFI: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. SANOFI: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. SANOFI: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. ASTRAZENECA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. ASTRAZENECA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. ASTRAZENECA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. PFIZER: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. PFIZER: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. PFIZER: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 56. ROCHE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 57. ROCHE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 58. ROCHE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 59. GILEAD SCIENCES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 60. GILEAD SCIENCES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 61. GILEAD SCIENCES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 62. CELGENE CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 63. CELGENE CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 64. CELGENE CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Biotechnology-Based Chemical Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved